药物研发-话题@MedSci

#药物研发#

120篇内容 | 3854人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301501, encodeId=f56d130150175, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕, objectType=article, longId=211976, objectId=8fc22119e6c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fc22119e6c8, replyNumber=0, likeNumber=69, createdTime=2021-05-30, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fc22119e6c8, moduleTitle=会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fc22119e6c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301500, encodeId=fef2130150058, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Nature:同期两篇！从基础研究到药物研发，李明团队发明“癌症环境免疫疗法”, objectType=article, longId=202395, objectId=56e1202395cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56e1202395cc, replyNumber=0, likeNumber=86, createdTime=2020-10-24, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56e1202395cc, moduleTitle=Nature:同期两篇！从基础研究到药物研发，李明团队发明“癌症环境免疫疗法”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56e1202395cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301499, encodeId=a4d413014998a, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=IDWeek 2020：默克公司将展示其广泛的抗感染药物研发管线, objectType=article, longId=202387, objectId=644e20238e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644e20238e88, replyNumber=0, likeNumber=81, createdTime=2020-10-24, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644e20238e88, moduleTitle=IDWeek 2020：默克公司将展示其广泛的抗感染药物研发管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644e20238e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301498, encodeId=d18d13014987f, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利, objectType=article, longId=202186, objectId=eff22021869f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eff22021869f, replyNumber=0, likeNumber=84, createdTime=2020-10-17, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eff22021869f, moduleTitle=9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eff22021869f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301497, encodeId=55f7130149eec, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=百时美施贵宝斥131亿美元收购心血管药物研发商 , objectType=article, longId=201808, objectId=854e201808dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=854e201808dc, replyNumber=0, likeNumber=92, createdTime=2020-10-09, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=854e201808dc, moduleTitle=百时美施贵宝斥131亿美元收购心血管药物研发商 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=854e201808dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301496, encodeId=f5a0130149601, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=乙肝创新药物研发方向、策略和管线概览, objectType=article, longId=198626, objectId=5db7198626a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5db7198626a4, replyNumber=0, likeNumber=90, createdTime=2020-08-04, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5db7198626a4, moduleTitle=乙肝创新药物研发方向、策略和管线概览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5db7198626a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301495, encodeId=087813014958c, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=抗体药物研发中具有重要作用的抗独特型抗体研究介绍, objectType=article, longId=196382, objectId=24941963827c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24941963827c, replyNumber=0, likeNumber=95, createdTime=2020-06-25, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24941963827c, moduleTitle=抗体药物研发中具有重要作用的抗独特型抗体研究介绍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24941963827c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301494, encodeId=9ef513014944d, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=一览：全球新冠疫苗与药物研发动态, objectType=article, longId=195442, objectId=059f195442aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=059f195442aa, replyNumber=0, likeNumber=85, createdTime=2020-06-08, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=059f195442aa, moduleTitle=一览：全球新冠疫苗与药物研发动态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=059f195442aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301493, encodeId=d9061301493c2, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=有效治疗炎症性疾病的药物研发出来了！, objectType=article, longId=195370, objectId=e4ee1953e083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ee1953e083, replyNumber=0, likeNumber=98, createdTime=2020-06-07, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ee1953e083, moduleTitle=有效治疗炎症性疾病的药物研发出来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ee1953e083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301492, encodeId=a26c1301492e4, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Inflammopharmacology：有效治疗炎症性疾病的药物研发出来了！, objectType=article, longId=195285, objectId=f5d419528555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d419528555, replyNumber=0, likeNumber=75, createdTime=2020-06-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d419528555, moduleTitle=Inflammopharmacology：有效治疗炎症性疾病的药物研发出来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5d419528555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301491, encodeId=1eb11301491a8, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=真实世界证据支持药物研发与审评的指导原则 (试行), objectType=article, longId=194267, objectId=06b319426ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06b319426ed1, replyNumber=0, likeNumber=89, createdTime=2020-05-18, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06b319426ed1, moduleTitle=真实世界证据支持药物研发与审评的指导原则 (试行), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06b319426ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301490, encodeId=cfb5130149068, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, objectType=article, longId=190910, objectId=dce919091038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dce919091038, replyNumber=0, likeNumber=58, createdTime=2020-03-28, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce919091038, moduleTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dce919091038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301489, encodeId=b8d6130148955, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=中科院副秘书长：新冠病毒变异并未影响药物研发及疫苗制备, objectType=article, longId=189528, objectId=adfb189528a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adfb189528a4, replyNumber=0, likeNumber=57, createdTime=2020-03-08, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adfb189528a4, moduleTitle=中科院副秘书长：新冠病毒变异并未影响药物研发及疫苗制备, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adfb189528a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301488, encodeId=15b213014888d, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=嵇元：标准随机对照临床试验不是新冠病毒药物研发的**选择, objectType=article, longId=189332, objectId=dd891893324b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd891893324b, replyNumber=0, likeNumber=63, createdTime=2020-03-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd891893324b, moduleTitle=嵇元：标准随机对照临床试验不是新冠病毒药物研发的**选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd891893324b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301487, encodeId=4305130148eeb, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=首批新冠肺炎人体疫苗来了！全球领先mRNA药物研发公司研制，已开启安全性临床试验, objectType=article, longId=188935, objectId=30b2188935aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30b2188935aa, replyNumber=0, likeNumber=76, createdTime=2020-02-29, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30b2188935aa, moduleTitle=首批新冠肺炎人体疫苗来了！全球领先mRNA药物研发公司研制，已开启安全性临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30b2188935aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301486, encodeId=cf7b130148666, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=专家解“毒”：为什么传染性强、药物研发难, objectType=article, longId=187889, objectId=9a3218e889ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a3218e889ec, replyNumber=0, likeNumber=63, createdTime=2020-02-14, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a3218e889ec, moduleTitle=专家解“毒”：为什么传染性强、药物研发难, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a3218e889ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301485, encodeId=8a7113014855a, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=中晟全肽：向全球药物研发机构免费开放超大型多肽库，快速推进抗2019-nCoV新药研究, objectType=article, longId=187452, objectId=73f818e4522e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73f818e4522e, replyNumber=0, likeNumber=58, createdTime=2020-02-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73f818e4522e, moduleTitle=中晟全肽：向全球药物研发机构免费开放超大型多肽库，快速推进抗2019-nCoV新药研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73f818e4522e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301484, encodeId=876d1301484d3, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=真实世界证据支持药物研发审评，这四点思考值得关注！, objectType=article, longId=186094, objectId=cfb618609476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfb618609476, replyNumber=0, likeNumber=74, createdTime=2020-01-13, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfb618609476, moduleTitle=真实世界证据支持药物研发审评，这四点思考值得关注！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfb618609476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301483, encodeId=620b1301483fc, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=真实世界证据支持药物研发与审评的指导原则（试行）, objectType=article, longId=186093, objectId=e6c718609392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6c718609392, replyNumber=0, likeNumber=75, createdTime=2020-01-13, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6c718609392, moduleTitle=真实世界证据支持药物研发与审评的指导原则（试行）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6c718609392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301482, encodeId=6ead1301482af, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=人工智能在药物研发领域的渗透, objectType=article, longId=184034, objectId=991218403422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=991218403422, replyNumber=0, likeNumber=72, createdTime=2019-12-04, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=991218403422, moduleTitle=人工智能在药物研发领域的渗透, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=991218403422)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药物研发

2020-05-29

huirong (审核中...)

前往app查看评论内容

#药物研发#

会议预告 | 人工智能赋能新时代已来，首届AI药物研发创新研讨会将于7月在沪开幕

2021-05-30

huirong (审核中...)

前往app查看评论内容

#药物研发#

Nature:同期两篇！从基础研究到药物研发，李明团队发明“癌症环境免疫疗法”

2020-10-24

huirong (审核中...)

前往app查看评论内容

#药物研发#

IDWeek 2020：默克公司将展示其广泛的抗感染药物研发管线

2020-10-24

huirong (审核中...)

前往app查看评论内容

#药物研发#

9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利

2020-10-17

huirong (审核中...)

前往app查看评论内容

#药物研发#

百时美施贵宝斥131亿美元收购心血管药物研发商

2020-10-09

huirong (审核中...)

前往app查看评论内容

#药物研发#

乙肝创新药物研发方向、策略和管线概览

2020-08-04

huirong (审核中...)

前往app查看评论内容

#药物研发#

抗体药物研发中具有重要作用的抗独特型抗体研究介绍

2020-06-25

huirong (审核中...)

前往app查看评论内容

#药物研发#

一览：全球新冠疫苗与药物研发动态

2020-06-08

huirong (审核中...)

前往app查看评论内容

#药物研发#

有效治疗炎症性疾病的药物研发出来了！

2020-06-07

huirong (审核中...)

前往app查看评论内容

#药物研发#

Inflammopharmacology：有效治疗炎症性疾病的药物研发出来了！

2020-06-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

真实世界证据支持药物研发与审评的指导原则 (试行)

2020-05-18

huirong (审核中...)

前往app查看评论内容

#药物研发#

关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知

2020-03-28

huirong (审核中...)

前往app查看评论内容

#药物研发#

中科院副秘书长：新冠病毒变异并未影响药物研发及疫苗制备

2020-03-08

huirong (审核中...)

前往app查看评论内容

#药物研发#

嵇元：标准随机对照临床试验不是新冠病毒药物研发的**选择

2020-03-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

首批新冠肺炎人体疫苗来了！全球领先mRNA药物研发公司研制，已开启安全性临床试验

2020-02-29

huirong (审核中...)

前往app查看评论内容

#药物研发#

专家解“毒”：为什么传染性强、药物研发难

2020-02-14

huirong (审核中...)

前往app查看评论内容

#药物研发#

中晟全肽：向全球药物研发机构免费开放超大型多肽库，快速推进抗2019-nCoV新药研究

2020-02-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

真实世界证据支持药物研发审评，这四点思考值得关注！

2020-01-13

huirong (审核中...)

前往app查看评论内容

#药物研发#

真实世界证据支持药物研发与审评的指导原则（试行）

2020-01-13

huirong (审核中...)

前往app查看评论内容

#药物研发#

人工智能在药物研发领域的渗透

2019-12-04

科室
- - 订阅+
  - 更多科室
工具
服务